4//SEC Filing
Moran James P 4
Accession 0001185185-23-000670
CIK 0001326205other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 1:46 PM ET
Size
17.8 KB
Accession
0001185185-23-000670
Insider Transaction Report
Form 4
Moran James P
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-31+50,000→ 100,000 total - Exercise/Conversion
Restricted Stock Units
2023-03-31−33,334→ 66,666 total→ Common Stock (33,334 underlying) - Award
Restricted Stock Units
2023-06-20+240,000→ 240,000 total→ Common Stock (240,000 underlying) - Award
Restricted Stock Units
2022-05-25+100,000→ 100,000 total→ Common Stock (100,000 underlying) - Exercise/Conversion
Restricted Stock Units
2023-03-31−50,000→ 50,000 total→ Common Stock (50,000 underlying) - Award
Restricted Stock Units
2023-06-20+200,000→ 200,000 totalExp: 2033-03-31→ Common Stock (200,000 underlying) - Exercise/Conversion
Common Stock
2023-03-31+33,334→ 133,334 total
Footnotes (5)
- [F1]Represents 150,000 restricted shares of IGC common stock subject to vesting equally over three years starting on January 18, 2022, and then on March 31, 2023, and 2024, as per the RSU Agreement with Director Moran.
- [F2]On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.
- [F3]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
- [F4]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
- [F5]Each restricted stock unit represents a right to receive one share of IGC common stock.
Documents
Issuer
IGC Pharma, Inc.
CIK 0001326205
Entity typeother
Related Parties
1- filerCIK 0001907094
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 1:46 PM ET
- Size
- 17.8 KB